A Phase 2 IV Gallium Study for Patients With Cystic Fibrosis (IGNITE Study)

Summary

The purpose of this study is to assess the efficacy of IV gallium to improve pulmonary function as measured by a 5% or greater relative improvement in forced expiratory volume in one second (FEV1) from baseline to Day 28. Funding Source - FDA OOPD

Timeline

Start

2016-03

Primary completion

2018-02-01

Completion

2018-02-01

Drugs

Indications